Novel SLC10A2 variants induce primary bile acid malabsorption and dysbiosis with IBD-like features.

What To Know

This report describes validated primary bile acid malabsorption (PBAM) from novel biallelic SLC10A2 variants found in a child first diagnosed with Crohn's disease and identifies similar genotypes on reanalysis of a pediatric IBD cohort.

For people with pediatric-onset IBD or Crohn-like presentations, the findings suggest genetic causes such as PBAM can mimic IBD and might warrant targeted testing when clinical features fit. The authors functionally validated that certain SLC10A2 gene variants cause PBAM and linked this to dysbiosis and IBD-like clinical features in at least one child.

The paper also reports reanalysis of a pediatric IBD cohort that found additional genotypes compatible with PBAM, supporting selective genetic testing in suggestive cases.

If you or a child with suspected Crohn's disease has atypical features (for example, poor response to standard IBD therapy or signs pointing toward bile acid malabsorption), clinicians may consider investigating genetic causes including SLC10A2-related PBAM.

This study is presented as an abstract-level article; it summarizes functional and cohort-reanalysis findings rather than providing full long-term clinical outcome data. The content here is based on the article abstract and partial extraction.

The study appears to be a clinical research report but details such as numbers of patients, specific methods, and clinical recommendations should be reviewed in the full paper or discussed with a clinician.